-
Prices double as private vaccines flood market
NEW DELHI: The Universal Immunisation Programme (UIP) seems to have slipped almost entirely into the grip of the private sector as the government's vaccine institutes that were reopened in February 2010 after being shut down two years ago are yet to contribute in any significant way. In the process, the cost of most vaccines has more than doubled since 2006-07.
- Categories
- Health Care
- Region
- South Asia
-
Lok Capital buys minority stake in social enterprise Drishti
Firm will use funds to service underserved geographies of Karnataka
- Categories
- Health Care, Investing
- Region
- South Asia
-
Disease burden links ecology to economic growth
A NEW study in the open access journal PLOS Biology, finds that vector-borne and parasitic diseases have substantial effects on economic development across the globe, and are major drivers of differences in income between tropical and temperate countries.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- public health
-
T cell ‘atlas’ paves way for new vaccines
COLUMBIA U. (US) — The first-ever “atlas” of immune cells in the human body may lead to new vaccine strategies and immunotherapies.
- Categories
- Health Care
-
India’s shift to inclusive innovation is ‘a model to follow’
A leading Indian scientist and policymaker is calling on developing countries to adopt an "emerging paradigm" of affordable, less complex and inclusive innovation to promote development and cut poverty.
- Categories
- Health Care
- Region
- South Asia
-
A ‘gold standard’ moment for evidence-based decision-making in global health
Each year, billions of dollars in foreign aid are earmarked for various global health priorities. The process by which any given health area ascends to priority status may vary with context, but as a global health community, we shoulder a collective responsibility to target our efforts based on reliable data that point to where the need is greatest.
- Categories
- Health Care
-
First New TB Drug In 50 Years Approved Must Be Made Widely Available
NEW YORK/GENEVA , December 31, 2012—The approval by the US Food and Drug Administration of an important new tuberculosis treatment must lead to its availability in countries with high levels of the drug-resistant form of the deadly disease
- Categories
- Health Care
-
Measles outbreak kills hundreds in Pakistan
An international health body says that the disease has killed more than 300 children in Pakistan's Sindh province.
- Categories
- Health Care
- Region
- South Asia